about
Nano-gold corking and enzymatic uncorking of carbon nanotube cupsSupramolecular Complexation of Carbohydrates for the Bioavailability Enhancement of Poorly Soluble DrugsPolysaccharide nanosystems for future progress in cardiovascular pathologiesCytocompatible and multifunctional polymeric nanoparticles for transportation of bioactive molecules into and within cellsNanogels of methylcellulose hydrophobized with N-tert-butylacrylamide for ocular drug delivery.Amino-functionalized cellulose nanoparticles: preparation, characterization, and interactions with living cells.Self-assembled poly(ε-caprolactone)-g-chondroitin sulfate copolymers as an intracellular doxorubicin delivery carrier against lung cancer cellsEnhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticlesPreparation and characterization of selenium incorporated guar gum nanoparticle and its interaction with H9c2 cells.Biocompatible ι-carrageenan-γ-maghemite nanocomposite for biomedical applications - synthesis, characterization and in vitro anticancer efficacy.Responsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriers.Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.Glyconanomaterials: Emerging applications in biomedical researchNanoparticle-aptamer bioconjugates for cancer targeting.Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.Design of siRNA Therapeutics from the Molecular ScaleExploiting endocytosis for nanomedicines.Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles.Nanostructured hyaluronic acid-based materials for active delivery to cancer.Biomolecule delivery to engineer the cellular microenvironment for regenerative medicine.Cationic nanoparticles for cancer therapy.The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.Ocular drug delivery - a look towards nanobioadhesives.Recent advances in the field of nanometric drug carriers.Polysaccharides as building blocks for nanotherapeutics.Endocytosis at the nanoscale.Application of polysaccharides for surface modification of nanomedicines.Engineering multifunctional nanoparticles: all-in-one versus one-for-all.Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies.Novel methods of targeted drug delivery: the potential of multifunctional nanoparticles.New views and insights into intracellular trafficking of drug-delivery systems by fluorescence fluctuation spectroscopy.Plasma and cellular pharmacokinetic considerations for the development and optimization of antitumor block copolymer micelles.Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy.Effect of the surface modification, size, and shape on cellular uptake of nanoparticles.Carbohydrate nanocarriers in biomedical applications: functionalization and construction.Targeted Nanotherapies for the Treatment of Surgical Diseases.Polyethylene sebacate doxorubicin nanoparticles: role of carbohydrate anchoring on in vitro and in vivo anticancer efficacy.A review of semi-synthetic biopolymer complexes: modified polysaccharide nano-carriers for enhancement of oral drug bioavailability.Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles.Carrageenan Based Bionanocomposites as Drug Delivery Tool with Special Emphasis on the Influence of Ferromagnetic Nanoparticles.
P2860
Q23924065-837334B6-AED4-4264-9B76-8010B1DE11A2Q26777831-68FD77FA-9E73-4C83-BF33-74D600581C93Q27025494-3B4082EC-4313-44B5-AD08-E8D1032F9703Q28821307-AEB9EA34-E772-47BF-A351-47493ACA0363Q31140602-93E35683-EBF3-45C7-85EA-B35F60EE444AQ34246722-E642524A-98A2-4AD9-8A02-DDDA67E13757Q34384085-765D7D32-FDAD-4D21-970E-04DEB446BA4BQ34573279-A1B77209-3FFA-4C41-ACFD-A3C6F9ACBC3FQ35009858-BD137658-7B07-4195-B0D4-6B1E54B030DFQ35166978-D858E1B3-9D7D-46F5-A732-D54E136EEADBQ35558487-8753964E-A4C7-4ADB-AE9F-12EE892A4196Q35837359-03A160F6-9040-4C6D-BC99-8D631A28D52BQ36197131-0C6DBD1B-C502-4718-BD58-F18C706979CCQ36460842-991EA894-5C66-473E-9269-FA9D0E3059B8Q36917923-876FDD8D-D934-4957-AC9E-F14EE012B9A0Q37111734-F9D50B7F-A2CD-4375-A21F-9D9A163AD446Q37258701-94B7B8CC-B497-4BF7-B655-3C9D35EF9D90Q37638568-CD0DB2FE-E12F-44A4-8B42-FF9970E073DCQ37724371-C225A142-F039-4B13-8119-EECBF1D9482AQ37735550-6CEE116F-48B4-462C-8A3E-F80D991949AAQ37743515-D8D92825-5129-4627-99CC-EB51BC80569BQ37815479-4108733E-9124-4F01-BA15-812B3C4E6740Q37822756-1B0A7422-090A-4C22-A640-B317F38A7BC3Q37855847-5AFEB079-F381-40B3-8A69-0D7DA86561C8Q37956480-15237BD5-8EBA-4F7C-868F-60B3EA5065B8Q37990464-17FAE446-5ED5-48B4-A85C-B4FFB4C1BA1EQ38074443-737F991F-66FB-494E-8437-1A132B0F70BEQ38085594-A1D8EBCF-5739-4C90-AE09-FF42E9E11011Q38166550-AD27ECA6-DC89-4C88-842E-7E731BE8E6F5Q38177370-AB7AD0F3-49A5-46BB-A76B-F0E642EF8226Q38183853-6EA4F2A9-4EC0-466E-A17B-4A3CE29214B1Q38248809-329D7030-1A79-4804-9BAC-2A13D6406911Q38383216-1CF6B2D4-7B3A-4BA2-BD44-C9D39AEADF64Q38384069-E29CEBBA-B3AC-4024-9D54-D522A71FB4E0Q38567851-22A892BD-F7D4-4F66-8354-D3E7866FE789Q38693341-C607C664-79DD-4FF0-BF45-410BCD498FEEQ38801585-F12FF8D3-D0C2-45F5-9170-ED1B211E4F81Q38911933-8F4B4DDF-4F5E-4986-83DD-E62CBEA00B5FQ38937583-115A43E9-2460-4B89-B769-0CECC9FD1726Q39183039-1B6D43D4-E813-4052-84F9-386CAF19DDA9
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Polysaccharide-decorated nanoparticles.
@ast
Polysaccharide-decorated nanoparticles.
@en
type
label
Polysaccharide-decorated nanoparticles.
@ast
Polysaccharide-decorated nanoparticles.
@en
prefLabel
Polysaccharide-decorated nanoparticles.
@ast
Polysaccharide-decorated nanoparticles.
@en
P1476
Polysaccharide-decorated nanoparticles.
@en
P2093
Caroline Lemarchand
P304
P356
10.1016/J.EJPB.2004.02.016
P407
P577
2004-09-01T00:00:00Z